Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation

Overview of attention for article published in Archives of Gerontology & Geriatrics, December 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 4 public wall posts from 2 users.

Led by WACHA’s Professor Christopher Etherton-Beer, the OptiMed deprescribing study was a double-blind RCT in RACFs where two…

The OptiMed deprescribing study was a double-blind RCT in RACFs where two pharmacists chose the medicines to target for…

The first two papers from the double blind placebo controlled study of deprescribing called Opti-Med are now published. This…

The first two papers from the double blind placebo controlled study of deprescribing called Opti-Med are now published. This…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.